Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Roche's MabThera garners EU clearance as first biologic therapy for pemphigus vulgaris

firstwordpharmaMarch 15, 2019

Tag: Roche , mabthera , pemphigus vulgaris

PharmaSources Customer Service